FIELD: pharmacology.
SUBSTANCE: invention relates to a compound represented by formula 1, its optical isomer or a pharmaceutically acceptable salt thereof: [Formula 1] 
, as well as to methods for its preparation and a pharmaceutical composition based on it.
EFFECT: new connections are obtained, with the ability to activate the GPR40 enzyme, suitable for use for metabolic disease prevention or treatment.
10 cl, 7 tbl, 77 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION CONTAINING NEW DERIVATIVE 3-(4-(BENZYLOXY)PHENYL)HEX-4-IN-ACID AND OTHER ACTIVE INGREDIENT TO ACTIVATE G-PROTEIN 40 OF THE RECEPTOR ENZYME | 2015 |
|
RU2680248C1 |
| NOVEL COMPOUNDS, ISOMERS THEREOF OR PHARMACUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUNDS | 2007 |
|
RU2448108C2 |
| METHOD OF ASSESSING THE QUALITY OF (3S)-3-(4-(3-(1,4-DIOXASPIRO[4,5]DEC-7-EN-8-YL)BENZYLOXY)PHENYL)HEX-4-YNOIC ACID | 2021 |
|
RU2804883C1 |
| QUINAZOLINE DERIVATIVES FOR SLOWING DOWN GROWTH OF CANCER CELLS AND METHOD OF OBTAINING THEM | 2005 |
|
RU2362773C2 |
| NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY | 2011 |
|
RU2585177C2 |
| GPR40 RECEPTOR AGONIST, METHODS OF PREPARING SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AS ACTIVE INGREDIENT | 2013 |
|
RU2650506C2 |
| INDOLE AND INDAZOLE DERIVATIVES SHOWING PRESERVING ACTION ON CELLS, TISSUES AND ORGANS | 2009 |
|
RU2460525C2 |
| NEW PYRIDINE DERIVATIVES, METHOD FOR MAKING THEREOF AND RELATED PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2366659C2 |
| INDOLE AND INDAZOLE COMPOUNDS AS CELLULAR NECROSIS INHIBITORS | 2008 |
|
RU2437883C1 |
| NEW CYCLOPENTA[B]FLUORENYL COOMPOUND OF TRANSITION METAL, CATALYTIC COMPOSITION CONTAINING IT, AND METHOD FOR PRODUCTION ETHYLENE HOMOPOLYMER OR ETHYLENE AND ALPHA-OLEFIN COPOLYMER AT ITS USE | 2012 |
|
RU2632895C2 |
